Benefit of Single Antiplatelet Therapy Over Dual Antiplatelet Therapy After Transcatheter Aortic Valve Implantation

Am J Cardiol. 2021 Feb 15:141:163-164. doi: 10.1016/j.amjcard.2020.12.010. Epub 2020 Dec 8.

Authors

Agam Bansal¹, Ashish Kumar¹, Vardhmaan Jain¹, Grant W Reed¹, Amar Krishnaswamy¹, Ankur Kalra¹, Rishi Puri¹, Samir R Kapadia²

Affiliations

¹ Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio.
² Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio. Electronic address: kapadis@ccf.org.

PMID: 33307014
DOI: 10.1016/j.amjcard.2020.12.010

No abstract available

Publication types

Comparative Study
Letter
Meta-Analysis

MeSH terms

Aortic Valve Disease / surgery*
Dual Anti-Platelet Therapy
Hemorrhage / epidemiology
Humans
Mortality*
Myocardial Infarction / epidemiology*
Platelet Aggregation Inhibitors / therapeutic use*
Postoperative Care
Risk Assessment
Stroke / epidemiology*
Transcatheter Aortic Valve Replacement*

Substances

Platelet Aggregation Inhibitors